Shawntel Swannack

Director, Central Monitoring and Data Analytics - GSK

Shawntel Swannack is the Director of Central Monitoring and Data Analytics at GSK. Her career has spanned over the last 22 years in clinical research as a coordinator at the site level, CRO Clinical Research Associate (CRA), Sponsor CRA, Data Management, Asset Lead, Central Monitoring Lead, Manager to Director. Her passion has always been driven to help people live their best lives. Whether for the patients' health through the clinical trials or the careers of her colleagues, seeing people thrive, inspires her desire for success. For the last 12 years, her passion for effective ways of working and day to day efficiencies with pristine focus on data integrity and quality has driven her career into central monitoring and data analytics space.

Shawntel Swannack


  • Thursday - September 22, 2022 - 13:55

    The effectiveness of new generation analytics models in RBM

    • Centralized monitoring can characterize key risk classifications and pointers from all clinical and operational source data available.
    • To evaluate risks to site performance, subject safety and data quality using Data and Analytics
    • Differentiating the relative risks between sites and subjects using the new age analytics models.


Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now